Zentalis Pharmaceuticals Inc. logo

Zentalis Pharmaceuticals Inc.

ZNTL | NASDAQ
Chart Builder DCF Calculator
$3.03
-$0.08 (-2.57%)
At close: Sep 21, 2026, 4:00 PM ET
$3.05
+$0.02 (+0.66%)
Pre-market: Sep 22, 2026, 8:14 AM ET
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Cash & Equivalents
36M 33.9M 28.04M 43.07M 59.96M 54.95M
Short-Term Investments
209.9M 337.18M 454.88M 394.3M 280.17M 283.55M
Long-Term Investments
n/a 2.63M 2.68M 23.84M 40.12M n/a
Other Long-Term Assets
6.74M 4.42M 6.82M 9.72M 7.04M 4.3M
Receivables
1.93M 5M n/a n/a 2.64M n/a
Inventory
n/a n/a n/a n/a n/a n/a
Other Current Assets
5.37M n/a 13.8M 14.56M n/a 417K
Total Current Assets
253.19M 386.07M 496.72M 451.93M 350.77M 345.1M
Property-Plant & Equipment
29.04M 37.23M 41.74M 50.08M 52.84M 3.62M
Goodwill & Intangibles
n/a n/a 3.74M 3.74M 3.74M 12.54M
Total Long-Term Assets
35.78M 44.27M 65.31M 101.52M 121.26M 20.45M
Total Assets
288.97M 430.34M 562.03M 553.46M 472.03M 365.56M
Account Payables
7.21M 7.44M 14.93M 11.25M 11.59M 8.66M
Deferred Revenue
n/a n/a 281K n/a n/a n/a
Short-Term Debt
3.87M 3.07M 2.62M n/a 1.45M n/a
Other Current Liabilities
15.51M 29.42M -2.9M 384K 20.68M 410K
Total Current Liabilities
36.56M 52.73M 69.37M 56.65M 43.94M 28.6M
Long-Term Debt
n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
500K 849K 1.78M 2.62M n/a 2.48M
Total Long-Term Liabilities
36.2M 40.43M 55.27M 62.79M 63.6M 3.58M
Total Liabilities
72.76M 93.15M 124.64M 119.43M 107.54M 32.18M
Total Debt
39.58M 42.65M 45.77M 47.33M 45.91M 2M
Book Value
216.2M 337.19M 437.39M 434.02M 364.48M 333.38M
Book Value Per Share
3.01 4.74 6.69 8.21 8.54 8.12
Common Stock
69K 71K 70K 59K 45K 41K
Retained Earnings
-1.19B -1.05B -888.56M -596.37M -359.56M -200.83M
Comprehensive Income
196K 558K 2.19M -1.35M -125K 36K
Shareholders Equity
216.2M 337.19M 437.28M 433.8M 363.95M 308.58M
Total Investments
209.9M 339.81M 457.56M 418.14M 320.3M 283.55M

© 2026 bestshares.com. All rights reserved.